Health and Fitness Health and Fitness
Tue, August 7, 2012
Mon, August 6, 2012
Fri, August 3, 2012
Thu, August 2, 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
00 p.m. EDT
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ] - Market Wire
Head of European Operations
Tue, July 31, 2012
Mon, July 30, 2012
Sun, July 29, 2012
Fri, July 27, 2012
Thu, July 26, 2012
Wed, July 25, 2012
Tue, July 24, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Neogen reports year end results
Mon, July 23, 2012
Sun, July 22, 2012
Sat, July 21, 2012
Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012

Notice of Paladin Labs' Second Quarter 2012 Results Conference Call


Published on 2012-07-26 05:45:50 - Market Wire
  Print publication without navigation


July 26, 2012 08:30 ET

Notice of Paladin Labs' Second Quarter 2012 Results Conference Call

MONTREAL, CANADA--(Marketwire - July 26, 2012) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, will release its second quarter 2012 financial results on Thursday, August 2, 2012 prior to market opening. Following the release, Paladin will hold a conference call at 10:00 a.m. (EDT) hosted by Mark Beaudet, interim President and CEO of Paladin Labs. Paladin cordially invites all interested parties to participate in this call.

CONFERENCE CALL DETAILS:

DATE:Thursday, August 2, 2012
TIME:10:00 a.m. EDT
DIAL IN NUMBER:1-800-891-9945 OR 416-981-9000
TAPED REPLAY: 1- 800-558-5253 OR 416-626-4100
Code: 21598039
Available from Thursday, August 2, 2012 at 12:00 p.m. until Saturday, September 1, 2012 at midnight.

The call will also be audio-cast live and archived for 30 days at [ www.paladinlabs.com ].

About Paladin Labs Inc.

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Company's web site at [ www.paladinlabs.com ].

This press release may contain forward-looking statements and predictions. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the Company and its subsidiaries, may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are discussed in the annual report as well as in the Company's Annual Information Form for the year ended December 31, 2010. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information or future events and except as required by law. For additional information on risks and uncertainties relating to these forward-looking statements, investors should consult the Company's ongoing quarterly fillings, annual report and Annual Information Form and other fillings found on SEDAR at [ www.sedar.com ].




Publication Contributing Sources